Literature DB >> 29602645

Changing the standard of care for treating melanoma brain metastases.

Paul B Chapman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29602645     DOI： 10.1016/S1470-2045(18)30187-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.

Authors:  Evan D Bander; Melissa Yuan; Joseph A Carnevale; Anne S Reiner; Katherine S Panageas; Michael A Postow; Viviane Tabar; Nelson S Moss
Journal:  Cancer       Date:  2021-03-02       Impact factor: 6.921

Review 2.  Comprehensive Clinical Trial Data Summation for BRAF-MEK Inhibition and Checkpoint Immunotherapy in Metastatic Melanoma.

Authors:  Jason J Luke
Journal:  Oncologist       Date:  2019-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.